Cardiac remodeling and treatment of other heart diseases

摘要

The present disclosure provides novel methods for treating cardiac remodeling and heart disease using specific compounds, as well as compositions and pharmaceutical formulations. In some embodiments, the compound may inhibit acetylation of MEF2 transcription factor.